Literature DB >> 15995950

The influence of chronic illnesses on the incidence of invasive pneumococcal disease in adults.

Moe H Kyaw1, Charles E Rose, Alicia M Fry, James A Singleton, Zack Moore, Elizabeth R Zell, Cynthia G Whitney.   

Abstract

Pneumococcal disease is more frequent and more deadly in persons with certain comorbidities. We used 1999 and 2000 data from the Active Bacterial Core surveillance (ABCs) and the National Health Interview Survey (NHIS) to determine rates of invasive pneumococcal disease in healthy adults (> or =18 years old) and in adults with various high-risk conditions. The risks of invasive pneumococcal disease in persons with specific chronic illnesses was compared with that in healthy adults, controlling for age, race, and the other chronic illnesses. Overall incidence rates, in cases/100,000 persons, were 8.8 in healthy adults, 51.4 in adults with diabetes, 62.9 in adults with chronic lung disease, 93.7 in adults with chronic heart disease, and 100.4 in adults who abused alcohol. Among the high-risk groups evaluated, risk was highest in adults with solid cancer (300.4), HIV/AIDS (422.9), and hematological cancer (503.1). Incidence rates increased with advancing age in adults with chronic lung disease, diabetes, and solid cancer. Black adults had higher incidence rates than white adults, both in healthy adults and in adults with chronic illnesses. These data support recommendations to provide pneumococcal vaccine to persons in these at-risk groups and underscore the need for better prevention strategies for immunocompromised persons.

Entities:  

Mesh:

Year:  2005        PMID: 15995950     DOI: 10.1086/431521

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  70 in total

1.  Socioeconomic and racial/ethnic disparities in the incidence of bacteremic pneumonia among US adults.

Authors:  Deron C Burton; Brendan Flannery; Nancy M Bennett; Monica M Farley; Ken Gershman; Lee H Harrison; Ruth Lynfield; Susan Petit; Arthur L Reingold; William Schaffner; Ann Thomas; Brian D Plikaytis; Charles E Rose; Cynthia G Whitney; Anne Schuchat
Journal:  Am J Public Health       Date:  2010-08-19       Impact factor: 9.308

2.  Identification of new risk factors for pneumonia: population-based case-control study.

Authors:  Yana Vinogradova; Julia Hippisley-Cox; Carol Coupland
Journal:  Br J Gen Pract       Date:  2009-10       Impact factor: 5.386

Review 3.  Pneumococcal vaccine and opsonic pneumococcal antibody.

Authors:  Joon Young Song; M Allen Moseley; Robert L Burton; Moon H Nahm
Journal:  J Infect Chemother       Date:  2013-05-09       Impact factor: 2.211

Review 4.  Adult vaccination.

Authors:  Kena A Swanson; H Josef Schmitt; Kathrin U Jansen; Annaliesa S Anderson
Journal:  Hum Vaccin Immunother       Date:  2014-11-01       Impact factor: 3.452

5.  Cost-effectiveness analysis of 13-valent pneumococcal conjugate vaccine versus 23-valent pneumococcal polysaccharide vaccine in an adult population in South Korea.

Authors:  Min-Joo Choi; Shin-On Kang; Jin-Jeong Oh; Seong-Beom Park; Min-Ja Kim; Hee-Jin Cheong
Journal:  Hum Vaccin Immunother       Date:  2018-07-11       Impact factor: 3.452

6.  Influence of chronic illnesses and underlying risk conditions on the incidence of pneumococcal pneumonia in older adults.

Authors:  Angel Vila-Corcoles; Carlos Aguirre-Chavarria; Olga Ochoa-Gondar; Cinta de Diego; Teresa Rodriguez-Blanco; Frederic Gomez; Xavier Raga; Luis Barnes; Ramon Magarolas; Leonardo Esteban
Journal:  Infection       Date:  2015-06-03       Impact factor: 3.553

7.  Cost-effectiveness of polysaccharide pneumococcal vaccination in people aged 65 and above in Poland.

Authors:  Pawel Grzesiowski; Raquel Aguiar-Ibáñez; Aleksandra Kobryń; Laure Durand; Pierre-Emmanuel Puig
Journal:  Hum Vaccin Immunother       Date:  2012-10-01       Impact factor: 3.452

8.  A retrospective analysis of hospital discharge records for S. pneumoniae diseases in the elderly population of Florence, Italy, 2010-2012.

Authors:  Angela Bechini; Cristina Taddei; Alessandro Barchielli; Miriam Levi; Emilia Tiscione; Maria Grazia Santini; Fabrizio Niccolini; Maria Teresa Mechi; Donatella Panatto; Daniela Amicizia; Chiara Azzari; Paolo Bonanni; Sara Boccalini
Journal:  Hum Vaccin Immunother       Date:  2014-11-01       Impact factor: 3.452

Review 9.  Preventing pneumococcal disease in the elderly: recent advances in vaccines and implications for clinical practice.

Authors:  Angel Vila-Corcoles; Olga Ochoa-Gondar
Journal:  Drugs Aging       Date:  2013-05       Impact factor: 3.923

10.  Population-based surveillance for invasive pneumococcal disease in homeless adults in Toronto.

Authors:  Agron Plevneshi; Tomislav Svoboda; Irene Armstrong; Gregory J Tyrrell; Anna Miranda; Karen Green; Donald Low; Allison McGeer
Journal:  PLoS One       Date:  2009-09-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.